Cargando…

A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old

Background: Respimat(®) Soft Mist™ Inhaler (SMI) is a hand-held device that generates an aerosol with a high, fine-particle fraction, enabling efficient lung deposition. The study objective was to assess inhalation success among children using Respimat SMI, and the requirement for assistance by the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamin, Wolfgang, Frank, Marion, Kattenbeck, Sabine, Moroni-Zentgraf, Petra, Wachtel, Herbert, Zielen, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601632/
https://www.ncbi.nlm.nih.gov/pubmed/25844687
http://dx.doi.org/10.1089/jamp.2014.1159
_version_ 1782394572745211904
author Kamin, Wolfgang
Frank, Marion
Kattenbeck, Sabine
Moroni-Zentgraf, Petra
Wachtel, Herbert
Zielen, Stefan
author_facet Kamin, Wolfgang
Frank, Marion
Kattenbeck, Sabine
Moroni-Zentgraf, Petra
Wachtel, Herbert
Zielen, Stefan
author_sort Kamin, Wolfgang
collection PubMed
description Background: Respimat(®) Soft Mist™ Inhaler (SMI) is a hand-held device that generates an aerosol with a high, fine-particle fraction, enabling efficient lung deposition. The study objective was to assess inhalation success among children using Respimat SMI, and the requirement for assistance by the parent/caregiver and/or a valved holding chamber (VHC). Methods: This open-label study enrolled patients aged <5 years with respiratory disease and history of coughing and/or recurrent wheezing. Patients inhaled from the Respimat SMI (air only; no aerosol) using a stepwise configuration: “1” (dose released by child); “2” (dose released by parent/caregiver), and “3” (Respimat SMI with VHC, facemask, and parent/caregiver help). Co-primary endpoints included the ability to perform successful inhalation as assessed by the investigators using a standardized handling questionnaire and evaluation of the reasons for success. Inhalation profile in the successful handling configuration was verified with a pneumotachograph. Patient satisfaction and preferences were investigated in a questionnaire. Results: Of the children aged 4 to <5 years (n=27) and 3 to <4 years (n=30), 55.6% and 30.0%, respectively, achieved success without a VHC or help; with assistance, another 29.6% and 10.0%, respectively, achieved success, and the remaining children were successful with VHC. All children aged 2 to <3 years (n=20) achieved success with the Respimat SMI and VHC. Of those aged <2 years (n=22), 95.5% had successful handling of the Respimat SMI with VHC and parent/caregiver help. Inhalation flow profiles generally confirmed the outcome of the handling assessment by the investigators. Most parent/caregiver and/or child respondents were satisfied with operation, instructions for use, handling, and ease of holding the Respimat SMI with or without a VHC. Conclusions: The Respimat SMI is suitable for children aged <5 years; however, children aged <5 years are advised to add a VHC to complement its use.
format Online
Article
Text
id pubmed-4601632
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Mary Ann Liebert, Inc.
record_format MEDLINE/PubMed
spelling pubmed-46016322015-10-20 A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old Kamin, Wolfgang Frank, Marion Kattenbeck, Sabine Moroni-Zentgraf, Petra Wachtel, Herbert Zielen, Stefan J Aerosol Med Pulm Drug Deliv Original Research Background: Respimat(®) Soft Mist™ Inhaler (SMI) is a hand-held device that generates an aerosol with a high, fine-particle fraction, enabling efficient lung deposition. The study objective was to assess inhalation success among children using Respimat SMI, and the requirement for assistance by the parent/caregiver and/or a valved holding chamber (VHC). Methods: This open-label study enrolled patients aged <5 years with respiratory disease and history of coughing and/or recurrent wheezing. Patients inhaled from the Respimat SMI (air only; no aerosol) using a stepwise configuration: “1” (dose released by child); “2” (dose released by parent/caregiver), and “3” (Respimat SMI with VHC, facemask, and parent/caregiver help). Co-primary endpoints included the ability to perform successful inhalation as assessed by the investigators using a standardized handling questionnaire and evaluation of the reasons for success. Inhalation profile in the successful handling configuration was verified with a pneumotachograph. Patient satisfaction and preferences were investigated in a questionnaire. Results: Of the children aged 4 to <5 years (n=27) and 3 to <4 years (n=30), 55.6% and 30.0%, respectively, achieved success without a VHC or help; with assistance, another 29.6% and 10.0%, respectively, achieved success, and the remaining children were successful with VHC. All children aged 2 to <3 years (n=20) achieved success with the Respimat SMI and VHC. Of those aged <2 years (n=22), 95.5% had successful handling of the Respimat SMI with VHC and parent/caregiver help. Inhalation flow profiles generally confirmed the outcome of the handling assessment by the investigators. Most parent/caregiver and/or child respondents were satisfied with operation, instructions for use, handling, and ease of holding the Respimat SMI with or without a VHC. Conclusions: The Respimat SMI is suitable for children aged <5 years; however, children aged <5 years are advised to add a VHC to complement its use. Mary Ann Liebert, Inc. 2015-10-01 /pmc/articles/PMC4601632/ /pubmed/25844687 http://dx.doi.org/10.1089/jamp.2014.1159 Text en © The Author(s) 2015; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Original Research
Kamin, Wolfgang
Frank, Marion
Kattenbeck, Sabine
Moroni-Zentgraf, Petra
Wachtel, Herbert
Zielen, Stefan
A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old
title A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old
title_full A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old
title_fullStr A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old
title_full_unstemmed A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old
title_short A Handling Study to Assess Use of the Respimat(®) Soft Mist™ Inhaler in Children Under 5 Years Old
title_sort handling study to assess use of the respimat(®) soft mist™ inhaler in children under 5 years old
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4601632/
https://www.ncbi.nlm.nih.gov/pubmed/25844687
http://dx.doi.org/10.1089/jamp.2014.1159
work_keys_str_mv AT kaminwolfgang ahandlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold
AT frankmarion ahandlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold
AT kattenbecksabine ahandlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold
AT moronizentgrafpetra ahandlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold
AT wachtelherbert ahandlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold
AT zielenstefan ahandlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold
AT kaminwolfgang handlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold
AT frankmarion handlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold
AT kattenbecksabine handlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold
AT moronizentgrafpetra handlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold
AT wachtelherbert handlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold
AT zielenstefan handlingstudytoassessuseoftherespimatsoftmistinhalerinchildrenunder5yearsold